Integra Lifesciences Holdings Corp
SWB:IL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Integra Lifesciences Holdings Corp
SWB:IL3
|
US |
|
Lubelski Wegiel Bogdanka SA
F:UXX
|
PL |
|
S
|
Swedish Match AB
F:SWMC
|
SE |
|
Meridian Mining UK Societas
TSX:MNO
|
UK |
|
L
|
Lubelski Wegiel Bogdanka SA
XMUN:UXX
|
PL |
Wall St Price Targets
IL3 Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for IL3 is 8.4 EUR with a low forecast of 6.77 EUR and a high forecast of 13.58 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IL3's stock price target?
Price Target
8.4
EUR
According to Wall Street analysts, the average 1-year price target for IL3 is 8.4 EUR with a low forecast of 6.77 EUR and a high forecast of 13.58 EUR.
What is the Revenue forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Gross Profit forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
